Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
1 The LEADER trial (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome ResultsA Long-Term Evaluation), a large double-blind, placebo-controlled trial, recently demonstrated that liraglutide added to standard therapy for a relatively short period of time (3.5-5 years) had a significant reduction in cardiovas-cular events and mortality compared to placebo in high-risk patients (hazard ratio [HR], 0.87
Bring back the passion and spark in your love life
GHK-Cu copper tripeptide in spray format
Dulaglutide can also cause side effects, including gastrointestinal symptoms and a boxed warning regarding thyroid C-cell tumors, and should only be used under the guidance of a licensed healthcare provider
Jun 2013;16(6):558-563
has acted as a speaker for Novo Nordisk and has received grants from Novo Nordisk, Novo Nordisk UK Research Foundation, Academy of Medical Sciences/ Diabetes UK and Health Education East Midlands
US$ 28.57
US$ 29.89
US$ 20.53
US$ 21.05
US$ 28.45
US$ 24.04
US$ 27.54
